Generic drugs are well entrenched in the United States drug supply chain. According to the latest data from IMS Health, generic drugs account for nearly 75% of all prescriptions dispensed in the U.S. today, and another $89 billion of branded drugs are considered at risk to generic competition through 2014 as their patents expire.
Click here for more.
